IDXG
Interpace Biosciences Inc
Halal Rating :
Last Price
$0.00
Last updated:
Market Cap
-
7D Change
-100.0%
1 Year Change
-100.0%
Company Overview
Industries
Exchange
Next Earnings Date
Interpace Biosciences Inc is a provider of molecular diagnostic tests, bioinformatics, and pathology services. The company specializes in early cancer detection and monitoring, with a focus on endocrine and related cancers. Their services include molecular diagnostic testing, anatomic pathology, and advanced bioinformatics solutions.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $12.29m | $10.54m | - | $145000.0 | 0.00% | 1.38% |
| June 30, 2024 | $12.04m | $9.97m | - | $188000.0 | 0.00% | 1.89% |
| March 31, 2024 | $10.27m | $9.62m | - | $216000.0 | 0.00% | 2.25% |
Company Impact
Help us evaluate Interpace Biosciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.